Evidence map›Paper›PMID 33786853›Full record

ArticleThe Journal of dermatology2021

Validation of measurement scores for evaluating vascular anomaly skin lesions.

Shiho Yasue, Michio Ozeki, Saori Endo, Takuma Ishihara, Mana Nishiguchi-Kurimoto, Masatoshi Jinnin, Miho Kawamura, Mariko Seishima, Hidenori Ohnishi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shiho YasueDepartment of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.ORCID https://orcid.org/0000-0001-6272-5638
Michio OzekiDepartment of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.ORCID https://orcid.org/0000-0001-9347-4448
Saori EndoDepartment of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
Takuma IshiharaInnovative and Clinical Research Promotion Center, Graduate School of Medicine, Gifu University, Gifu, Japan.
Mana Nishiguchi-KurimotoDepartment of Dermatology, Graduate School of Medicine, Gifu University, Gifu, Japan.ORCID https://orcid.org/0000-0002-5991-3950
Masatoshi JinninDepartment of Dermatology, Graduate School of Medicine, Gifu University, Gifu, Japan.ORCID https://orcid.org/0000-0001-9230-6207
Miho KawamuraDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.
Mariko SeishimaDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan.ORCID https://orcid.org/0000-0003-0007-3632
Hidenori OhnishiDepartment of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
Gifu University · JPWakayama Medical University · JP

Funding

Japan's Agency for Medical Research and Development 0201089Japan's Agency for Medical Research and Development 19lkJapan's Agency for Medical Research and Development h0001The Ministry of Health Labour and Welfare
6 · The paper itself

Abstract

Vascular anomalies comprise a heterogeneous group of disorders caused by abnormal proliferation or development of vascular and/or lymphatic vessels. Vascular anomalies present with various symptoms and complications, but no standardized methods evaluate their severity, and to measure treatment outcomes is difficult. To assess the responsiveness of measurement scores for evaluating vascular anomaly skin lesions, we conducted a validation study to compare these measurement scores with patients' objective data. In this study, data were collected from treated and untreated patients. Skin lesions were photographed at baseline and after a follow-up period of 3-6 months. The volume of skin lesions, the degree of red or purple coloration, and color tone were measured objectively. Two external dermatologists evaluated patients' photographs and determined scores, which represented criteria for improvements in skin lesions (size and color) and 6-point Physician Global Assessment scores. The correlation between these scores and patients' objective data (lesion volume and color) was assessed to validate the scores. Twenty-three cases of vascular anomaly (seven vascular tumors, five lymphatic malformations, three venous malformations, and eight lymphatic-venous malformations) were examined. Scores for improvements in vascular anomaly skin lesions (size and color) correlated with a change in lesion volume, the degree of red or purple coloration, color tone score, and 6-point Physician Global Assessment score. Our findings suggest that these measurement scores are responsive to changes in vascular anomaly skin lesions after observation.

Indexed as

Lymphatic AbnormalitiesLymphatic VesselsSkin DiseasesVascular MalformationsHumansVeinsdisease scoring systemdrug treatmentlymphatic malformationvascular tumorvenous malformation

Identifiers

PMID33786853
PMCPMC8360112
OpenAlexW3139754880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.